BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He H, Trpkov K, Martinek P, Isikci OT, Maggi-Galuzzi C, Alaghehbandan R, Gill AJ, Tretiakova M, Lopez JI, Williamson SR, Montiel DP, Sperga M, Comperat E, Brimo F, Yilmaz A, Pivovarcikova K, Michalova K, Slouka D, Prochazkova K, Hora M, Bonert M, Michal M, Hes O. "High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases. Virchows Arch 2018;473:725-38. [PMID: 30232607 DOI: 10.1007/s00428-018-2456-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Xia QY, Wang XT, Zhao M, He HY, Fang R, Ye SB, Li R, Wang X, Zhang RS, Lu ZF, Ma HH, Wang ZY, Rao Q. TSC/MTOR-associated Eosinophilic Renal Tumors Exhibit a Heterogeneous Clinicopathologic Spectrum: A Targeted Next-generation Sequencing and Gene Expression Profiling Study. Am J Surg Pathol 2022. [PMID: 35980750 DOI: 10.1097/PAS.0000000000001955] [Reference Citation Analysis]
2 Menz A, Gorbokon N, Viehweger F, Lennartz M, Hube-Magg C, Hornsteiner L, Kluth M, Völkel C, Luebke AM, Fraune C, Uhlig R, Minner S, Dum D, Höflmayer D, Sauter G, Simon R, Burandt E, Clauditz TS, Lebok P, Jacobsen F, Steurer S, Krech T, Marx AH, Bernreuther C. Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors. Int J Surg Pathol 2022;:10668969221117243. [PMID: 35946088 DOI: 10.1177/10668969221117243] [Reference Citation Analysis]
3 Argani P, Matoso A, Pallavajjalla A, Haley L, Tseh-Lin M, Ng J, Chow CW, Lotan T, Mehra R. Xanthomatous Giant Cell Renal Cell Carcinoma: Another Morphologic Form of TSC-associated Renal Cell Carcinoma. Am J Surg Pathol 2022. [PMID: 35941720 DOI: 10.1097/PAS.0000000000001940] [Reference Citation Analysis]
4 Amin MB, McKenney JK, Martignoni G, Campbell SC, Pal S, Tickoo SK. Low grade oncocytic tumors of the kidney: a clinically relevant approach for the workup and accurate diagnosis. Mod Pathol 2022. [PMID: 35896615 DOI: 10.1038/s41379-022-01108-5] [Reference Citation Analysis]
5 Alaghehbandan R, Williamson SR, McKenney JK, Hes O. The Histologic Diversity of Chromophobe Renal Cell Carcinoma With Emphasis on Challenges Encountered in Daily Practice. Adv Anat Pathol 2022;29:194-207. [PMID: 35470289 DOI: 10.1097/PAP.0000000000000349] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mirkheshti N, Farrukh N, Legesse T, Rowe SP, Gordetsky J, Hussain A. Renal oncocytoma: a challenging diagnosis. Current Opinion in Oncology 2022;34:243-52. [DOI: 10.1097/cco.0000000000000829] [Reference Citation Analysis]
7 Paner GP, Chumbalkar V, Montironi R, Moch H, Amin MB. Updates in Grading of Renal Cell Carcinomas Beyond Clear Cell Renal Cell Carcinoma and Papillary Renal Cell Carcinoma. Adv Anat Pathol 2022;29:117-30. [PMID: 35275846 DOI: 10.1097/PAP.0000000000000341] [Reference Citation Analysis]
8 Tomaszewski Z, Littler Y. Unclassified Oncocytic Renal Neoplasm with Rib and Liver Metastases: Metastatic Oncocytoma? Int J Surg Pathol 2022;:10668969221084265. [PMID: 35274993 DOI: 10.1177/10668969221084265] [Reference Citation Analysis]
9 Pivovarcikova K, Alaghehbandan R, Vanecek T, Ohashi R, Pitra T, Hes O. TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background. Biomedicines 2022;10:322. [DOI: 10.3390/biomedicines10020322] [Reference Citation Analysis]
10 Argani P, Mehra R. Renal cell carcinoma associated with tuberous sclerosis complex (TSC)/mammalian target of rapamycin (MTOR) genetic alterations. Mod Pathol 2022. [PMID: 35046523 DOI: 10.1038/s41379-021-00971-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
11 Alaghehbandan R, Przybycin CG, Verkarre V, Mehra R. Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates. Asian Journal of Urology 2021. [DOI: 10.1016/j.ajur.2021.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Akgul M, Williamson SR. Immunohistochemistry for the diagnosis of renal epithelial neoplasms. Semin Diagn Pathol 2022;39:1-16. [PMID: 34823973 DOI: 10.1053/j.semdp.2021.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Alaghehbandan R, Limani R, Ali L, Rogala J, Vanecek T, Steiner P, Hajkova V, Kuthi L, Slisarenko M, Michalova K, Pivovarcikova K, Hora M, Pitra T, Michal M, Hes O. Clear cell renal cell carcinoma with prominent microvascular hyperplasia: Morphologic, immunohistochemical and molecular-genetic analysis of 7 sporadic cases. Ann Diagn Pathol 2021;56:151871. [PMID: 34847388 DOI: 10.1016/j.anndiagpath.2021.151871] [Reference Citation Analysis]
14 Mohanty SK, Satapathy A, Aggarwal A, Mishra SK, Sampat NY, Sharma S, Williamson SR. Oncocytic renal neoplasms with diffuse keratin 7 immunohistochemistry harbor frequent alterations in the mammalian target of rapamycin pathway. Mod Pathol 2021. [PMID: 34802045 DOI: 10.1038/s41379-021-00969-6] [Reference Citation Analysis]
15 Wang G, Amin MB, Grossmann P, Ptáková N, Hayes M, Hartmann A, Agaimy A, Lopez JI, Michal M, Hes O. Renal cell tumor with sex-cord/gonadoblastoma-like features: analysis of 6 cases. Virchows Arch 2021. [PMID: 34775513 DOI: 10.1007/s00428-021-03235-x] [Reference Citation Analysis]
16 Henske EP, Cornejo KM, Wu CL. Renal Cell Carcinoma in Tuberous Sclerosis Complex. Genes (Basel) 2021;12:1585. [PMID: 34680979 DOI: 10.3390/genes12101585] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
17 Kapur P, Gao M, Zhong H, Chintalapati S, Mitui M, Barnes SD, Zhou Q, Miyata J, Carrillo D, Malladi VS, Rakheja D, Pedrosa I, Xu L, Kinch L, Brugarolas J. Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney. Mod Pathol 2021. [PMID: 34538873 DOI: 10.1038/s41379-021-00896-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Luo X, Preciado C, Nayak A, Schwartz LE, Guzzo TJ, Williamson SR, Palmer MB, Lal P. Renal Oncocytoma With Both Lymphovascular Invasion and Prominent Intracytoplasmic Vacuole-Like Spaces: A Case Report and Review of the Literature. Int J Surg Pathol 2021;:10668969211041592. [PMID: 34488464 DOI: 10.1177/10668969211041592] [Reference Citation Analysis]
19 Polifka I, Ohashi R, Moch H. [Oncocytic tumours of the kidney-new differential diagnoses]. Pathologe 2021;42:551-9. [PMID: 34468818 DOI: 10.1007/s00292-021-00979-w] [Reference Citation Analysis]
20 Bergmann L, Weber S, Hartmann A, Ahrens M. Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview. Expert Rev Anticancer Ther 2021;:1-14. [PMID: 34291700 DOI: 10.1080/14737140.2021.1959319] [Reference Citation Analysis]
21 Kapur P, Gao M, Zhong H, Rakheja D, Cai Q, Pedrosa I, Margulis V, Xu L, Kinch L, Brugarolas J. Eosinophilic Vacuolated Tumor of the Kidney: A Review of Evolving Concepts in This Novel Subtype With Additional Insights From a Case With MTOR Mutation and Concomitant Chromosome 1 Loss. Adv Anat Pathol 2021;28:251-7. [PMID: 34009776 DOI: 10.1097/PAP.0000000000000299] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
22 Baniak N, Barletta JA, Hirsch MS. Key Renal Neoplasms With a Female Predominance. Adv Anat Pathol 2021;28:228-50. [PMID: 34009777 DOI: 10.1097/PAP.0000000000000301] [Reference Citation Analysis]
23 Caliò A, Brunelli M, Gobbo S, Argani P, Munari E, Netto G, Martignoni G. Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors. Cancers (Basel) 2021;13:2441. [PMID: 34069976 DOI: 10.3390/cancers13102441] [Reference Citation Analysis]
24 Munari E, Settanni G, Caliò A, Segala D, Lonardi S, Sandrini S, Vacca P, Tumino N, Marconi M, Brunelli M, Gobbo S, Netto GJ, Moretta L, Zamboni G, Martignoni G. TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study. Mod Pathol 2021. [PMID: 33990704 DOI: 10.1038/s41379-021-00816-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Polifka I, Agaimy A, Moch H, Hartmann A. [Histological subtypes of renal cell carcinoma : Overview and new developments]. Pathologe 2021;42:294-304. [PMID: 33825093 DOI: 10.1007/s00292-021-00937-6] [Reference Citation Analysis]
26 Iakymenko OA, Delma KS, Jorda M, Kryvenko ON. Cathepsin K (Clone EPR19992) Demonstrates Uniformly Positive Immunoreactivity in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Distal Tubules. Int J Surg Pathol 2021;29:600-5. [PMID: 33764165 DOI: 10.1177/1066896921991588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Cimadamore A, Cheng L, Scarpelli M, Massari F, Mollica V, Santoni M, Lopez-Beltran A, Montironi R, Moch H. Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review. Transl Androl Urol 2021;10:1506-20. [PMID: 33850785 DOI: 10.21037/tau-20-1150] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
28 Giunchi F, Franceschini T, Fiorentino M. A narrative review of individualized treatments of genitourinary tumors: is the future brighter with molecular evaluations? Transl Androl Urol 2021;10:1553-61. [PMID: 33850789 DOI: 10.21037/tau-20-1185] [Reference Citation Analysis]
29 Ishikawa N, Kimura N, Yoshida T, Yoshimura I, Nakahara K, Tsuzuki T, Tokunaga O. A Case of Low-Grade Oncocytic Tumor/Chromophobe Renal Cell Carcinoma (Oncocytic Variant) of the Kidney. Case Rep Pathol 2021;2021:6684777. [PMID: 33680526 DOI: 10.1155/2021/6684777] [Reference Citation Analysis]
30 Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen Y, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-galluzzi C, Mckenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Hes O. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol 2021;34:1167-84. [DOI: 10.1038/s41379-021-00737-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
31 Athanazio DA, Amorim LS, da Cunha IW, Leite KRM, da Paz AR, de Paula Xavier Gomes R, Tavora FRF, Faraj SF, Cavalcanti MS, Bezerra SM. Classification of renal cell tumors – current concepts and use of ancillary tests: recommendations of the Brazilian Society of Pathology. Surg Exp Pathol 2021;4. [DOI: 10.1186/s42047-020-00084-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Gupta S, Jimenez RE, Herrera-Hernandez L, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Cheville JC. Renal Neoplasia in Tuberous Sclerosis: A Study of 41 Patients. Mayo Clin Proc 2021;96:1470-89. [PMID: 33526281 DOI: 10.1016/j.mayocp.2020.11.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
33 Tjota MY, Wanjari P, Segal J, Antic T. TSC/MTOR-mutated eosinophilic renal tumors are a distinct entity that is CK7+/CK20-/vimentin-: a validation study. Hum Pathol 2021;115:84-95. [PMID: 33352195 DOI: 10.1016/j.humpath.2020.12.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
34 Papathomas T, Tzortzakakis A, Sun N, Erlmeier F, Feuchtinger A, Trpkov K, Bazarova A, Arvanitis A, Wang W, Bozoky B, Kokaraki G, Axelsson R, Walch A. In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on 99mTc-sestamibi Single Photon Emission Computed Tomography/Computed Tomography Examination. Eur Urol Open Sci 2020;22:88-96. [PMID: 34337482 DOI: 10.1016/j.euros.2020.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Argani P, Reuter VE, Eble JN, Vlatkovic L, Yaskiv O, Swanson D, Dickson BC, Antonescu CR, Matoso A, Gagan J, Palsgrove DN. Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma (BHP RCC): A Distinctive Neoplasm Associated With Somatic NF2 Mutations. Am J Surg Pathol 2020;44:901-16. [PMID: 32217839 DOI: 10.1097/PAS.0000000000001467] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
36 Williamson SR, Gill AJ, Argani P, Chen YB, Egevad L, Kristiansen G, Grignon DJ, Hes O. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer. Am J Surg Pathol 2020;44:e47-65. [PMID: 32251007 DOI: 10.1097/PAS.0000000000001476] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 9.5] [Reference Citation Analysis]
37 de Andrade Melo CGR, Xavier MVN, Pimenta IS, Athanazio DA. Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive). Surg Exp Pathol 2020;3. [DOI: 10.1186/s42047-020-00074-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Shah RB, Stohr BA, Tu ZJ, Gao Y, Przybycin CG, Nguyen J, Cox RM, Rashid-Kolvear F, Weindel MD, Farkas DH, Trpkov K, McKenney JK. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity. Am J Surg Pathol 2020;44:571-81. [PMID: 31850909 DOI: 10.1097/PAS.0000000000001422] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
39 Roldan-romero JM, Santos M, Lanillos J, Caleiras E, Anguera G, Maroto P, García-donas J, de Velasco G, Martinez-montes ÁM, Calsina B, Monteagudo M, Letón R, Leandro-garcía LJ, Montero-conde C, Cascón A, Robledo M, Rodriguez-antona C. Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome. Mod Pathol 2020;33:2580-90. [DOI: 10.1038/s41379-020-0607-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
40 Akgul M, Cheng L. Immunophenotypic and pathologic heterogeneity of unclassified renal cell carcinoma: a study of 300 cases. Hum Pathol 2020;102:70-8. [PMID: 32619439 DOI: 10.1016/j.humpath.2020.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Williamson SR, Cardili L, Whiteley LJ, Sanchez J, Kis O. Sclerosing TSC1 mutated renal cell carcinoma: An unusual pattern mimicking MITF family translocation renal cell carcinoma. Genes Chromosomes Cancer 2020;59:591-4. [PMID: 32418252 DOI: 10.1002/gcc.22860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Abdessater M, Kanbar A, Comperat E, Dupont-Athenor A, Alechinsky L, Mouton M, Sebe P. Renal Oncocytoma: An Algorithm for Diagnosis and Management. Urology 2020;143:173-80. [PMID: 32512107 DOI: 10.1016/j.urology.2020.05.047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
43 Liu YJ, Houldsworth J, Emmadi R, Dyer L, Wolff DJ. Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup. Cancer Genet 2020;244:40-54. [PMID: 32434132 DOI: 10.1016/j.cancergen.2020.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
44 Siadat F, Trpkov K. ESC, ALK, HOT and LOT: Three Letter Acronyms of Emerging Renal Entities Knocking on the Door of the WHO Classification. Cancers (Basel) 2020;12:E168. [PMID: 31936678 DOI: 10.3390/cancers12010168] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
45 Alaghehbandan R, Perez Montiel D, Luis AS, Hes O. Molecular Genetics of Renal Cell Tumors: A Practical Diagnostic Approach. Cancers (Basel) 2019;12:E85. [PMID: 31905821 DOI: 10.3390/cancers12010085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
46 Williamson SR. Renal cell carcinomas with a mesenchymal stromal component: what do we know so far? Pathology 2019;51:453-62. [DOI: 10.1016/j.pathol.2019.04.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
47 Trpkov K, Bonert M, Gao Y, Kapoor A, He H, Yilmaz A, Gill AJ, Williamson SR, Comperat E, Tretiakova M, Magi-Galluzzi C, Brimo F, Hes O. High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex. Histopathology 2019;75:440-2. [PMID: 31002177 DOI: 10.1111/his.13876] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
48 Trpkov K, Williamson SR, Gao Y, Martinek P, Cheng L, Sangoi AR, Yilmaz A, Wang C, San Miguel Fraile P, Perez Montiel DM, Bulimbasić S, Rogala J, Hes O. Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity? Histopathology 2019;75:174-84. [PMID: 30895640 DOI: 10.1111/his.13865] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]